Multivitamin/mineral supplementation seems not to be associated with cardiovascular disease outcomes.
Screening for coexisting diseases may help identify high-risk patients with intracranial atherosclerotic disease.
Clinicians need to consider treatments for episodic migraine that may be contraindicated if a patient also has cardiovascular disease.
While the increase in cardiovascular risk factors is at least partially due to the obesity epidemic, the researchers believe the increase is multifactorial.
Risks of adverse cardiovascular-related outcomes or mortality are not reduced with CPAP treatment.
Clinicians should make patients aware of their increased risk for stroke and heart attack.
Men who received testosterone replacement therapy had lower odds of cardiovascular events.
Previous research has suggested that statins and PCSK9 inhibitors may adversely affect cognition.
Standardized definitions were proposed for stroke, hypoxic-ischemic injury, and cerebral hemorrhage.
Early intervention in patients with heart failure or atrial fibrillation may help delay or prevent the onset of mild dementia.
Patients receiving treatment with vitamin K antagonists (VKA) or antiplatelet agents face a significantly increased risk of mortality within 24 hours of intracranial hemorrhage.
A significant inverse trend was observed between the Healthy Nordic Food Index and risk of stroke.
Patients with elevated levels of activity in the amygdala were at higher risk for cardiovascular events.
Patients who received ACE inhibitors showed a slower progression of myocardial fibrosis and fewer cardiovascular events.
Patients experienced a 34% risk of a reduction in the ability to perform daily tasks independently.
Amyloid beta protein accumulation was present in the hearts of patients with Alzheimer's disease.
Half of patients experienced a reduction in seizure frequency after statin initiation.
Women with a history of migraine headache had a more than 2-fold increased risk of stroke over a 6-year follow-up period.
Those with previous cognitive impairment saw a more pronounced improvement.
Patients with Alzheimer's disease tended to have increased thickness in the wall of their left ventricle.
The effect of antihypertensive drugs and stains on cognition is uncertain.
Long episodes of AT/AF were more likely to be associated with clinical events than short episodes.
A committee from the American Heart Association failed to make specific clinical recommendations for the management of hypertension related to cognitive impairment.
Vascular disease can have a negative impact on cognition and motor phenotype in PD.
At baseline, 83% of the patients had established cardiovascular disease, chronic kidney disease, or both.
In subjects with a low risk of preclinical Alzheimer's disease indexed by the absence of MTA, findings were confirmed.
The researchers noted that CPAP users may not be using the device long enough to see benefits for their cardiovascular health.
Studies have linked GCA with increased risk of VTE; however, results have been compromised by limited data sets.
Doctors should be monitoring for high blood pressure and cholesterol in this patient population.
Both lesion count and volume was less in the treatment group vs controls.
Neurology Advisor Articles
- Vitamin D3 Associated With Reductions in Migraine Days Among Migraineurs
- Hemicrania Continua: Diagnosis and Treatment
- Psychiatric Adverse Effects from Levetiracetam Linked to Certain Factors
- Lorcaserin May Reduce Motor Seizures in Pediatric Treatment-Resistant Epilepsy
- Generic Lamotrigine, Levetiracetam Formulations Comparable to Brand Name AEDs